- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02516735
I-scan With Magnification for the Detection of Gastric Intestinal Metaplasia
August 3, 2015 updated by: Yanqing Li, Shandong University
I-scan With Magnification Targeted Biopsies Compared With a Standard Biopsy Protocol for the Detection of Gastric Intestinal Metaplasia in a High Risk Population: a Randomized Controlled Trial
The purpose of this study is to assess whether i-scan with magnification can reduce the biopsy number needed per patient for the detection of gastric intestinal metaplasia without the loss of corresponding diagnostic yield.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Gastric intestinal metaplasia is regarded as an important premalignant lesion for intestinal type gastric cancer.
Currently, the histological assessment of gastric intestinal metaplasia still relies on the biopsies took from five sites that the updated Sydney System recommended.
However, the updated Sydney System biopsy protocol needs more biopsy number and procedure time, for it is unable to satisfy the diagnosis of gastric intestinal metaplasia.
I-scan is a novel image-enhanced endoscopy system based on the post processing of reflected light without optical filters.
Targeted biopsy protocol based on i-scan with magnification will be possible for the diagnosis of gastric intestinal metaplasia.
This study aims to compare the diagnostic yield of gastric intestinal metaplasia from i-scan with magnification targeted biopsies and a standard biopsy protocol and assess whether i-scan with magnification can reduce the biopsy number needed per patient for the detection of gastric intestinal metaplasia without the loss of corresponding diagnostic yield.
Study Type
Interventional
Enrollment (Anticipated)
164
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yanqing Li, PhD. MD.
- Phone Number: 82169508 18678827666
- Email: qiluliyanqing@gmail.com
Study Locations
-
-
Shandong
-
Jinan, Shandong, China, 250012
- Recruiting
- Department of Gastroenterology, Qilu Hospital, Shandong University
-
Contact:
- Yanqing Li, PhD. MD.
- Phone Number: 82169508 18678827666
- Email: qiluliyanqing@gmail.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 80 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- patients with dyspeptic symptoms and aged 40 years or older
- or patients with Helicobacter pylori infection, or histologically verified gastric intestinal metaplasia or atrophic gastritis
- or patients with family history of gastric cancer
Exclusion Criteria:
- presence of gastrectomy, acute gastrointestinal bleeding, or known gastric neoplasia
- presence of conditions unsuitable for endoscopy procedure including coagulopathy, impaired cardiopulmonary function , pregnancy or breastfeeding
- inability to provide informed consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: DIAGNOSTIC
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Group 1
I-scan with magnification targeted biopsies for gastric intestinal metapalsia.
|
|
ACTIVE_COMPARATOR: Group 2
Standard endoscopy with a standard biopsy protocol from the five standard biopsy sites following the updated Sydney System including two from the distal antrum (within 2-3cm from the pylorus, greater/lesser curvature), one from the incisura and two from the mid corpus (greater/lesser curvature).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Difference of the detection rate of gastric intestinal metaplasia between i-scan with magnification targeted biopsies and standard endoscopy with standard biopsy protocol in a per-pateint analysis
Time Frame: seven months
|
seven months
|
Difference of the detection rate of gastric intestinal metaplasia between i-scan with magnification targeted biopsies and standard endoscopy with standard biopsy protocol in a per-biopsy analysis
Time Frame: seven months
|
seven months
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Number of biopsies needed in per group
Time Frame: seven months
|
seven months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (ANTICIPATED)
November 1, 2015
Study Registration Dates
First Submitted
July 30, 2015
First Submitted That Met QC Criteria
August 3, 2015
First Posted (ESTIMATE)
August 6, 2015
Study Record Updates
Last Update Posted (ESTIMATE)
August 6, 2015
Last Update Submitted That Met QC Criteria
August 3, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015SDU-QILU-G07
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastric Intestinal Metaplasia
-
Shandong UniversityUnknownGastric Intestinal Metaplasia | Confocal Laser Endomicroscopy | Biopsy | Operative Link on Gastric Intestinal MetaplasiaChina
-
Xijing Hospital of Digestive DiseasesCompleted
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
Shandong UniversityCompletedGastric Intestinal MetaplasiaChina
-
Shandong UniversityUnknownGastric Intestinal MetaplasiaChina
-
King Chulalongkorn Memorial HospitalCompletedGastric Intestinal MetaplasiaThailand
-
King Chulalongkorn Memorial HospitalUnknownGastric Intestinal MetaplasiaThailand
-
Shandong UniversityNot yet recruitingHelicobacter Pylori | the Operative Link on Gastric Intestinal Metaplasia | Operative Link on Gastric Intestinal AssessmentChina
-
The University of Hong KongCompletedIntestinal Metaplasia | Gastric DysplasiaHong Kong
Clinical Trials on I-scan with magnification
-
Instituto Ecuatoriano de Enfermedades DigestivasActive, not recruiting
-
Seoul National University HospitalCompletedIntestinal PolypsKorea, Republic of
-
Instituto Ecuatoriano de Enfermedades DigestivasCompletedGERD | Non Erosive Reflux DiseaseEcuador
-
Indiana University School of MedicineCompletedCrohn's Disease | Ulcerative ColitisUnited States
-
Johns Hopkins UniversityNational Eye Institute (NEI); Visionize, LLCCompletedLow VisionUnited States
-
Instituto Ecuatoriano de Enfermedades DigestivasCompletedGastritis | Helicobacter Pylori Infection | Intestinal Metaplasia | Gastritis, AtrophicEcuador
-
Sheffield Teaching Hospitals NHS Foundation TrustCompletedEndoscopyUnited Kingdom
-
University of CalgaryUnknown
-
Imperial College LondonCompleted